HeART of Stroke: randomised controlled, parallel-arm, feasibility study of a community-based arts and health intervention plus usual care compared with usual care to increase psychological well-being in people following a stroke by Ellis-Hill, Caroline et al.
1Ellis-Hill C, et al. BMJ Open 2019;9:e021098. doi:10.1136/bmjopen-2017-021098
Open access 
HeART of Stroke: randomised 
controlled, parallel-arm, feasibility 
study of a community-based arts and 
health intervention plus usual care 
compared with usual care to increase 
psychological well-being in people 
following a stroke
Caroline Ellis-Hill,1 Sarah Thomas,1 Fergus Gracey,2,3 Catherine Lamont-Robinson,4 
Robin Cant,5 Elsa M R Marques,6 Peter W Thomas,1 Mary Grant,7 
Samantha Nunn,3 Thomas Paling,6 Charlotte Thomas,1 Alessa Werson,2 
Kathleen T Galvin,8 Frances Reynolds,9 Damian Jenkinson10
To cite: Ellis-Hill C, Thomas S, 
Gracey F, et al.  HeART of 
Stroke: randomised controlled, 
parallel-arm, feasibility study 
of a community-based arts 
and health intervention plus 
usual care compared with usual 
care to increase psychological 
well-being in people 
following a stroke. BMJ Open 
2019;9:e021098. doi:10.1136/
bmjopen-2017-021098
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2017- 
021098).
Received 15 December 2017
Revised 14 June 2018
Accepted 21 August 2018
For numbered affiliations see 
end of article.
Correspondence to
Dr Caroline Ellis-Hill;  
 cehill@ bournemouth. ac. uk
Research
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction People often experience distress following 
stroke due to fundamental challenges to their identity.
Objectives To evaluate (1) the acceptability of ‘HeART of 
Stroke’ (HoS), a community-based arts and health group 
intervention, to increase psychological well-being; and (2) 
the feasibility of a definitive randomised controlled trial 
(RCT).
Design Two-centre, 24-month, parallel-arm RCT with 
qualitative and economic components. Randomisation 
was stratified by centre and stroke severity. Participant 
blinding was not possible. Outcome assessment blinding 
was attempted.
setting Community.
Participants Community-dwelling adults ≤2 years 
poststroke recruited via hospital clinical teams/databases 
or community stroke/rehabilitation teams.
Interventions Artist-facilitated arts and health group 
intervention (HoS) (ten 2-hour sessions over 14 weeks) 
plus usual care (UC) versus UC.
Outcomes The outcomes were self-reported measures 
of well-being, mood, capability, health-related quality of 
life, self-esteem and self-concept (baseline and 5 months 
postrandomisation). Key feasibility parameters were 
gathered, data collection methods were piloted, and 
participant interviews (n=24) explored the acceptability of 
the intervention and study processes.
results Despite a low recruitment rate (14%; 95% CI 11% 
to 18%), 88% of the recruitment target was met, with 29 
participants randomised to HoS and 27 to UC (57% male; 
mean (SD) age=70 (12.1) years; time since stroke=9 (6.1) 
months). Follow-up data were available for 47 of 56 (84%; 
95% CI 72% to 91%). Completion rates for a study-specific 
resource use questionnaire were 79% and 68% (National 
Health Service and societal perspectives). Five people 
declined HoS postrandomisation; of the remaining 24 who 
attended, 83% attended ≥6 sessions. Preliminary effect 
sizes for candidate primary outcomes were in the direction 
of benefit for the HoS arm. Participants found study 
processes acceptable. The intervention cost an estimated 
£456 per person and was well-received (no intervention-
related serious adverse events were reported).
Conclusions Findings from this first community-
based study of an arts and health intervention for 
people poststroke suggest a definitive RCT is feasible. 
Recruitment methods will be revised.
trial registration number ISRCTN99728983.
IntrODuCtIOn
Each year over 150 000 people in the UK 
experience a stroke,1 with one-third left with 
residual disabilities including paralysis on 
one side and cognitive and communication 
impairments.2 Qualitative meta-syntheses 
have highlighted that following a stroke, 
strengths and limitations of this study
 ► This is the first feasibility study of a communi-
ty-based arts and health group intervention to sup-
port well-being following a stroke.
 ► Participants were recruited via both hospital and 
community clinical teams, enabling recruitment rate 
estimates for two different recruitment approaches.
 ► The study incorporated mixed methods and a feasi-
bility economic component.
 ► The study only included short-term follow-up.
 ► Findings will inform a definitive randomised con-
trolled trial of effectiveness and cost-effectiveness.
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or other types of brain injury, people face fundamental 
emotional and existential challenges. They experience 
challenges to their sense of self and identity, and their 
current and future lives are filled with uncertainty.3 4 
Emotional health and well-being following stroke have 
been highlighted as national priorities, featuring in the 
James Lind Alliance ‘top ten’ research priorities.5 
Following a stroke people report a need to ‘get their 
lives back’. Failure to do so is associated with depres-
sion6 7 (with reported accumulative incidence of 39%–52% 
within 5 years of stroke7), loss of confidence,8 having diffi-
culty in ‘feeling part of things’,9 loss of sense of self10 and 
becoming socially isolated.11 This creates long-term costs 
for the stroke survivor and family members,12 13 and for 
government, health and social services through reduced 
family employment and increased social and primary 
care needs.14 Left untreated, depression is associated with 
poorer functional outcomes15 and higher mortality.16 17
While there have been great improvements in stroke 
care, the stroke pathway for long-term support is still 
under-researched and under-developed. A Cochrane 
review indicated no evidence for pharmacotherapy in 
the prevention of poststroke depression, and only weak 
evidence for psychotherapeutic approaches.18 A more 
recent systematic review,19 that limited inclusion to partic-
ipants without a diagnosis of depression at baseline, 
concluded that antidepressants may reduce the likeli-
hood of depression developing poststroke, but that the 
optimal timing and duration of treatment were not clear. 
There is also evidence to suggest that pharmacological 
treatments can have modest benefits in the treatment of 
depression poststroke.20–23 However, antidepressants have 
side effects and may have undesirable interactions with 
other medications and/or comorbidities.20–23
While the evidence for the effectiveness of psychother-
apeutic interventions for poststroke depression is incon-
clusive,20 two recent randomised controlled trials (RCTs) 
(motivational interviewing24 25 and a brief psychosocial 
behavioural intervention plus antidepressant26) demon-
strated reductions in poststroke depression. However, 
these trials involved people early after stroke and excluded 
those with severe communication or cognitive problems. 
The CALM (Communication and Low Mood) trial27 of 
behavioural therapy demonstrated improved mood in 
patients with stroke with aphasia, and a feasibility study of 
behavioural activation is now under way using a broader 
sample of people with depression 3–60 months post-
stroke.28 A study of cognitive behavioural therapy (CBT) 
for poststroke depression demonstrated no benefits over 
usual care or an attention control; however, the sample 
size was small.29
Around 20% of people experience clinical levels of 
anxiety following stroke.30 A recent Cochrane review 
highlighted the need for further rigorously conducted 
RCTs to assess pharmacological and psychological treat-
ments for anxiety following stroke.30
A stepped approach to psychological support following 
stroke has been proposed in the UK31 (step 1: awareness, 
watching; step 2: low-intensity services, such as guided 
self-help; step 3: high-intensity services, such as CBT), but 
this system is still in its infancy.
Harrison et al32 concluded from qualitative research with 
service users that research is needed to test alternative 
options to formal psychological support. Ellis-Hill et al33 
and Gracey et al34 have independently developed comple-
mentary theoretical models based on empirical evidence to 
understand the processes involved in re-establishing a posi-
tive sense of self and confidence in life following a stroke. 
The current research draws on two specific and related 
theoretical frameworks; namely, the life thread model33 and 
self-discrepancy theory.9 34 These highlight that following 
an acquired brain injury people often lose a sense of coher-
ence of self and a sense of predictability in life. These exis-
tential losses can cause considerable anxiety and can lead 
to depression. Within neuropsychological rehabilitation, it 
is hypothesised that establishing a safe place where clients 
feel understood and supported can facilitate self-develop-
ment.34 35 When carrying out embodied creative activities 
(such as art), people can reconnect their past, present and 
future selves, recreating meaningful narratives in their 
lives and new ways of ‘being in the world’,36 37 leading to 
improvements in mood and self-confidence.
There is increasing recognition of the importance of 
creative approaches in health provision; for example, 
in the UK we have seen the launch of a national Special 
Interest Group for Arts, Health and Wellbeing (now part 
of the Culture, Health and Well-being Alliance) supported 
by the Royal Society for Public Health38 and the All-Party 
Parliamentary Group enquiry into arts, health and well-
being in the UK.39 Practical creative approaches offer new 
ways to explore experiences, especially those which are 
difficult to put into words.40 There is a growing body of 
evidence that art-based practices are of great benefit in 
supporting psychological and social recovery in health 
services39 and an emerging international agenda for 
‘Arts for Health’ initiatives.41 An ongoing prospective 
observational study (2009–2016) of patients referred to 
an 8-week or 10-week ‘arts on referral’ programme in UK 
general practice (n=1297) found statistically significant 
improvements in well-being in those who completed their 
prescribed programme.42 Boyce et al’s43 critical review of 
the value of arts in healthcare highlighted that, although 
findings are promising, research to date has been rela-
tively narrow both in scope (a focus on music) and meth-
odological approach. They called for methodologically 
rigorous research that considers different art forms in a 
variety of healthcare settings and their cost-effectiveness.
In stroke, initial findings from exploratory studies of 
the effect of art on mood have been promising.44 45 To 
our knowledge, there are only two other RCTs of arts and 
health interventions in stroke, both of which took place 
in inpatient rehabilitation settings.46 47 Kongkasuwan et 
al’s study in Thailand involved 118 patients with stroke 
and compared ‘creative art therapy’ plus standard physio-
therapy with physiotherapy only.46 The creative art therapy 
was delivered by art therapists twice a week over 4 weeks 
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and included music, singing and meditation in addition 
to the creative art therapy activities. They found improve-
ments favouring the intervention group post-treatment 
in measures of mood, cognition, physical functioning 
and quality of life. Morris et al’s47 48 UK randomised 
controlled feasibility study (n=81) compared an artist-de-
livered visual arts participation programme (up to eight 
sessions including individual and group delivery formats) 
with usual care. They concluded that the intervention was 
feasible to deliver and appeared to offer promise in the 
domains of emotional well-being and self-efficacy.
White et al49 highlighted that community participation 
and stroke-related disability are potentially modifiable 
risk factors affecting poststroke health-related quality of 
life and that interventions addressing these factors should 
be developed and tested. This feasibility study50 is the first 
to begin to systematically test an arts and health interven-
tion (‘HeART of Stroke’ (HoS)) for people poststroke in 
a community setting.
MethODs
Aims and objectives
The aims of the feasibility study were, first, to assess the 
acceptability of a 10-session community arts and health 
group intervention (‘HeART of Stroke’) for people 
following stroke, and second to evaluate the feasibility 
of conducting a definitive RCT to test its effectiveness 
and cost-effectiveness when added to usual care. The 
following were the specific objectives:
1. Assess the acceptability of key aspects of study design, 
randomisation and recruitment processes, and of the 
HoS group intervention.
2. Estimate recruitment and short-term retention rates.
3. Estimate HoS group attendance rates.
4. Assess the suitability of the outcome measures and 
feasibility of the assessment strategy.
5. Refine the selection of the outcome measures, in par-
ticular to help inform the selection of the primary 
outcome for the full-scale RCT.
6. Explore, qualitatively, individuals’ experiences of par-
ticipating in the study and gather feedback about the 
intervention and outcome measures.
7. Collect data on the SDs of outcome measures to in-
form a sample size calculation for a larger trial and 
obtain preliminary estimates of effect size.
8. Refine the HoS group intervention and its delivery.
9. Explore differences in processes between the two 
study centres.
10. Identify, measure and value resources required to de-
liver the intervention in the community.
11. Develop and pilot data collection tools to measure 
resource use in the follow-up period to inform the 
design of a future within-trial economic evaluation, 
and estimate the cost of delivering HoS.
study design
This was a two-centre, parallel-arm, randomised controlled 
feasibility study comparing the HoS group intervention 
plus usual care versus usual care alone (1:1 allocation 
ratio), with nested economic and qualitative components.
For reasons of efficiency and expediency, the end point 
of this feasibility study was 1 month postintervention, 
but a definitive trial would include up to 12 months of 
follow-up postintervention to capture the longer term 
health and economic impact of the HoS intervention. 
One month post-treatment was chosen as the study end 
point rather than the end of treatment (1) because some 
of the outcome measures include items with 4-week recall 
periods (eg, Short-Form 36 (SF-36)) and (2) to reduce 
the likelihood of capturing transient disappointment 
about the group coming to an end in those who attended 
a HoS group.
Patient and public involvement
Patients and the public were involved in the initiation and 
design of the study, the development of the funding appli-
cation, the design of the HoS intervention, the selection 
of relevant outcome measures and the design of study 
materials. During the research, in addition to RC, a grant 
holder, who attended all steering group and dissemina-
tion meetings, we formed patient and public involvement 
groups in each centre. There were five patient and public 
involvement members in Bournemouth (four involved 
in the study at any one time). Members came from the 
local voluntary ‘Different Strokes’ group, the Royal Bour-
nemouth and Christchurch Hospitals (RBCH) NHS 
Foundation Trust stroke ward patient and public involve-
ment group, and via word of mouth from these members. 
Four members were several years following their stroke 
and one person was a caregiver. There were three patient 
and public involvement members in Cambridgeshire: 
one was identified through a previous research role and 
two were identified through community organisations 
(Stroke Association and National Health Service (NHS) 
community services). All were several years poststroke.
As planned, patient and public involvement members 
were involved in three of the five study management 
group meetings. A newsletter kept patient and public 
involvement members updated with study progress. 
Members contributed to the study in many ways, including 
providing feedback about outcome measures, providing 
opportunities for the researchers to run through/practise 
aspects of the study protocol, helping to identify a suit-
able venue for the intervention, providing ideas on how 
to enhance recruitment, contributing to plain English 
summaries, and supporting the exhibition of artwork and 
other dissemination activities. Examples of dissemina-
tion activities undertaken include a workshop at the UK 
Stroke Forum codelivered by a study participant with two 
members of the research team (CL-R and CE-H), local 
newspaper coverage and articles in magazines.
Methods
Details of our methods are published in our protocol 
paper.50 We aimed to recruit a sample of 64 people (32 
per centre in two blocks of 16). This would have provided 
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an estimate of the recruitment rate with a precision of 
±6% (assuming a recruitment rate of 30%) and a ques-
tionnaire return rate with a precision of ±10% (assuming 
a questionnaire return rate of 80%). Reporting of this 
feasibility study follows the Consolidated Standards 
of Reporting Trials (CONSORT) 2010 extension for 
randomised pilot and feasibility trials.51
Participants
Participants were adults living in the community up to 
2 years poststroke. This time point was chosen as the peak 
incidence and greatest severity of depression commonly 
occur between 6 months and 2 years following stroke.52 
Participants also had physical or cognitive symptoms from 
stroke at 5 days poststroke. Severity of stroke and cogni-
tive impairment are risk factors for the development of 
poststroke depression.53 People who have fully recovered 
physically and cognitively within this short time point may 
be less likely to benefit from the intervention. Exclusion 
criteria included severe receptive aphasia, cognitive levels 
that would preclude completion of outcome measures 
even with support, currently receiving a psychiatric or 
clinical psychology intervention, living in a residential 
or nursing home, and requiring assistance with toilet 
needs (because the arts and health practitioners were not 
trained to support transfers).
Identification, screening and recruitment
Bournemouth Centre, UK (RBCH NHS Foundation Trust)
Potential participants, identified by clinical research 
network staff at the RBCH NHS Foundation Trust, were 
either sent or given an invitation letter, ‘Key Facts’ page 
and reply slip and asked to return a prepaid reply slip if 
they were interested in participating. The study research 
assistant contacted those who expressed an interest and 
answered any queries or questions (via telephone, or face-
to-face if the person had a communication disability). If 
they were still interested in taking part, they were sent or 
given a set of participant information sheets.
In an attempt to improve recruitment, we revised the 
invitation and reminder letters partway through the 
study via an approved substantial amendment to the 
NHS Research Ethics Committee. Our patient and public 
involvement partners and clinical colleagues in the stroke 
research team at RBCH provided feedback to enhance 
the appeal and readability of the information via a more 
accessible and engaging style.
Cambridgeshire Centre, UK (Cambridgeshire Community Services 
NHS Trust)
Clinical staff from the community stroke and neuroreha-
bilitation teams identified potential participants in the 
community. In addition to the invitation letter described 
above, a ‘consent to contact’ approach was used whereby 
consent to be contacted by the Cambridgeshire centre 
research assistant was sought. A member of the clinical 
team obtained this consent during a face-to-face consulta-
tion or verbally over the phone. If the individual remained 
interested, the research assistant gave or sent them a set 
of participant information sheets.
Informed consent process
For individuals interested in taking part, the local 
research assistant arranged to visit the person at home 
within 1 month prior to the start of the HoS group. This 
provided an opportunity to answer any remaining ques-
tions the individual had about the study. If the person 
still fulfilled the eligibility criteria (a screening checklist 
was used) and still wished to take part, they were asked 
to complete and sign a consent form and complete the 
baseline assessment.
randomisation
The web-based randomisation system was created by the 
Peninsula Clinical Trials Unit at Plymouth University in 
conjunction with the study statistician. Participants were 
allocated to the HoS intervention plus usual care or 
usual care in a 1:1 ratio using minimisation to balance 
the numbers allocated to each arm with stratification by 
recruitment centre and stroke severity (Rivermead Motor 
Assessment-gross function subscale score ≤6 (‘mild’) vs 
≥7 (‘moderate/severe’)).54 The study research assistants 
in each centre logged onto the system using a unique 
username and password. They were able to randomise 
participants individually or in batches. Randomisation of 
individuals was used to ‘top up’ the two trial arms if any 
further participants were recruited before the HoS inter-
vention groups started.
blinding
The nature of the intervention meant that it was not 
possible to blind participants and artist facilitators to 
group allocation. At follow-up, when support was required 
to complete outcome measures, this was provided by 
assessors blind to group allocation.
hos group intervention
The HoS intervention is described in detail in the 
published protocol.50 In summary, it comprised ten 2-hour 
arts and health practitioner-led group sessions held in 
community venues over 14 weeks. Sessions were held in 
the mornings (10:30–12:30) with a refreshment break. 
Sessions 1–3 included introductions and initial explora-
tion. During sessions 4–7 participants were encouraged 
to develop their own creative practice within the sessions 
and at home. In sessions 8–10 links with local arts and 
health practitioners were made and potential plans for an 
exhibition of the participants’ work discussed.
Key aspects of the group were the opportunity to be 
creative and the safe group atmosphere. At each group, 
the arts and health practitioners encouraged members to 
(1) explore the materials provided and arts techniques 
shared; (2) explore their senses and support others’ 
explorations; (3) be non-judgemental of self/others; (4) 
follow and respond to their own interests; and (5) develop 
a sense of play/improvisation. The arts and health prac-
titioners prepared resources (including paints, drawing 
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materials, clay, textiles and mixed-media) in response to 
the group members’ individual and collective creative 
interests and skills. The group was offered ‘stimulus’ 
pieces such as books, poems, images, music and film, and 
members were encouraged to share their own pieces of 
interest with the group.
Examples of artwork produced can be seen in figure 1 
and figure 2.
Following each session, the arts and health practitioner 
briefly documented observations and reflected further 
to inform the selection of materials and activity for the 
next session. Practitioners also provided participants with 
sketchbooks and/or paper and other arts materials to 
support their emerging interests between sessions.
The rationale of HoS is to provide a safe space through 
the medium of arts in which group members have the 
opportunity to reconnect with their internal selves 
through their senses and embodied knowing and connect 
with, and support, others. This was a face-to-face group 
intervention, with self-directed individual art activity 
opportunities between meetings. Standardisation was 
linked with the context and setting rather than specified 
activities carried out by the practitioners and participants 
as this was expected to vary due to the creative nature 
of the activity. For example, standardisation included the 
groups taking place in a non-medical setting, so that the 
arts and health practitioners could create and hold a safe 
space in which participants felt able to express themselves 
creatively. The focus was the person not their stroke. The 
artists responded to and followed the interests of each 
participant, rather than solely ‘teaching’ arts skills.
Facilitators and venues
The groups were facilitated by arts and health practi-
tioners, with at least 5 years’ arts and health practice 
experience, who were able to support groups, create 
and hold a safe space, and who were willing and able to 
support arts practice where participants took the lead in 
their own discovery and exploration. Currently in the UK, 
arts and health practitioners are not required to under-
take specific training but characteristically develop their 
practice within NHS initiatives working alongside experi-
enced artist mentors or with respected ‘Arts on Prescrip-
tion’ organisations. One arts and health practitioner led 
both groups in Bournemouth (CL-R) and two led one 
group each in Cambridgeshire. They had access to exper-
tise in stroke (CE-H) and clinical psychology (FG). For 
the purposes of the project, a researcher was also present 
on site, if needed. The researcher supported study admin-
istration aspects (such as travel expenses for participants) 
and participant completion of a scale (Doosje et al’s Social 
Identification self-report scale) assessing group fit/sense 
of belonging.55
In Bournemouth the HoS groups (iterations 1 and 2) 
were held in a church hall, and in Cambridgeshire they 
were held either in a room in a community hospital 
site on the edge of Cambridge city used by Headway 
Cambridgeshire (a local brain injury charity) (itera-
tion 3) or a community centre in a very rural north 
Cambridgeshire town (iteration 4). All venues had 
disabled access/toilet facilities, access to water and a sink, 
and tea/coffee-making facilities and could accommodate 
up to eight participants (potentially with wheelchairs) 
around a table. There were storage facilities (although 
limited) in Cambridgeshire but none in the Bour-
nemouth venue. Transport was provided for those unable 
to make their own way to the venue.
Usual care
In Bournemouth, support is provided by the Early 
Supported Discharge multidisciplinary team for 2–6 
weeks after leaving hospital and then medical care via the 
general practitioner (GP), with a referral to the stroke 
coordinator. People with complex medical conditions 
are seen by stroke consultants as hospital outpatients. 
Figure 1 Drawing by FB.
Figure 2 Painting by MDBD.
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Ongoing rehabilitation needs are met by rehabilitation 
teams and day hospital service provision in some areas. 
In Cambridgeshire, medical care is delivered via the GP 
and people with complex medical conditions are seen by 
stroke consultants as hospital outpatients. At the time of 
the study all could access support from the Stroke Asso-
ciation ‘Information, Advice and Support Coordinator’ 
and may have received additional therapy or support via 
one of three locality-based neurorehabilitation teams. 
Participants in both arms of the trial received usual care, 
and usual care was not affected by involvement in the 
trial.
Descriptors and proposed outcome measures
Demographic/descriptor variables and stroke-related information
At baseline the local research assistant collected informa-
tion during a home visit about age, sex, marital status, 
educational qualifications, ethnicity, household compo-
sition, employment situation, comorbidities, medication, 
type of stroke, stroke side, time since stroke, mobility 
(Rivermead Motor Assessment-gross function subscale),54 
upper limb impairment (Motricity Index),56 communica-
tion ability (Boston Severity Rating Scale)57 and cognitive 
ability (Addenbrooke’s Cognitive Examination-Revised; 
ACE-R).58
Outcome measures
The outcome measures (see below) were self-reported 
and presented in a booklet in a large font (pt 14). At base-
line, outcome measures were administered face-to-face by 
a research assistant in participants’ homes. At approxi-
mately 5 months postrandomisation (1 month post-HoS 
intervention), outcome measures were administered by 
post, or if needed, with face-to-face or telephone support 
from a blinded assessor (one in each centre). At the end 
of the questionnaire booklet, there was a question that 
asked whether participants had received any support 
from others to complete it, with the following response 
options possible: none, researcher on phone, researcher 
at house, family member/friend. Participants were asked 
not to disclose their allocation arm to the blinded asses-
sors. In each centre the blinded assessors were asked to 
guess participants’ treatment allocation.
In line with the feasibility objectives of this study, three 
outcome measures were included for consideration as 
potential candidates for the primary outcome in a subse-
quent full trial:
1. Warwick-Edinburgh Mental Well-being Scale 
(WEMWBS).59
2. Hospital Anxiety and Depression Scale (HADS).60
3. ICEpop CAPability measure for adults (ICECAP-A).61
In addition, the following outcome measures were 
included as potential secondary outcomes:
1. Rosenberg Self-Esteem Scale (RSES).62
2. Medical Outcomes Short Form Health Survey (SF-36 
V.1).63
3. Head Injury Semantic Differential Scale (HISDS-III).64
Serious adverse events and adverse events
Serious adverse events (SAEs) and adverse events (AEs) 
were closely monitored, documented and reported as 
described in the study protocol.50
Process measures
Doosje et al’s Social Identification self-report scale55 was 
used to measure ‘sense of belonging’ by participants 
in the HoS group at the end of the first, fifth and final 
sessions.
Identifying, measuring and valuing resource use
Resources required to deliver the HoS intervention 
were recorded for each session on forms completed by 
the artist facilitators. These included artists’ preparation 
time, travel time to and from the venue, time spent deliv-
ering the intervention, equipment and materials used, 
number of participants attending the sessions, and venue 
hire costs. Resources were valued using local estimates 
provided by the experienced artists delivering HoS. Artist 
facilitators’ time was valued at the fixed fee of £120 per 
session (to cover travel, preparation and delivery costs), 
with an additional £25 fee for materials and £8 for refresh-
ments. Venue hire costs in Bournemouth (iterations 1 
and 2) were £40 per session, and in Cambridgeshire £100 
per session (iteration 3) and £25 per session (iteration 4). 
We envisage the roll-out of the HoS intervention would 
follow a similar model whereby the healthcare provider 
would pay the artist facilitators a fixed delivery fee. Partic-
ipant travel costs to attend sessions were recorded and are 
reported.
Resources required to deliver usual care in both arms 
were collected via a bespoke telephone-administered 
resource use questionnaire that asked about resources 
used in the period following randomisation. Participants 
were posted the questionnaire in advance of the tele-
phone interview and were offered face-to-face support 
to complete it, if required. The questionnaire included 
hospital visits and admissions, use of community and 
social services, time off work and social activities, informal 
care, other sources of support, expenses incurred and 
medications. As service users advised us that it would be 
difficult to distinguish between stroke-related resource 
use and resource use related to comorbidities, the ques-
tionnaire asked respondents to report resources related 
to all their healthcare needs. We assume that, in a defin-
itive RCT, any differences between arms would result 
from the HoS intervention effect. To improve comple-
tion rates,65 participants were provided with a resource 
use log to record healthcare visits prospectively, if they 
wished. Resources were valued using Curtis and Burns’ 
Unit Costs of Health and Social Care66 and the 2015 
Department of Health NHS reference costs.67 Private 
expenses were self-reported. Hours of informal care 
and time off work and social activities were valued using 
the Office for National Statistics (2015) average weekly 
earnings.68
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Qualitative descriptive interviews
Face-to-face interviews with 12 people (8 intervention; 4 
usual care) were undertaken in people’s homes across 
both centres by CE-H on two occasions: (1) postrando-
misation but before the HoS intervention was delivered; 
and (2) at study end after all outcome measures had been 
completed. Purposive sampling was used to capture vari-
ations that might influence perceptions, including age, 
sex, communication disability and severity of stroke. The 
preintervention topics included why the person decided 
to take part in the overall study, their views on the recruit-
ment and initial assessment process, and (intervention 
group only) expectations in terms of the HoS group 
intervention. The postintervention topics included views 
on the study and outcome assessment processes and the 
acceptability of completing outcomes at 1-year follow-up 
in the context of a hypothetical future trial. Intervention 
participants were also asked about their experiences of 
the group, the venues and their ability/willingness to pay 
their own transport costs to attend HoS.
Analysis
Quantitative analysis
Quantitative analysis was carried out using IBM SPSS 
V.23.0 and STATA V.14. The person undertaking the 
analysis was blind to allocation and group assignment was 
coded using 0 and 1. As this was a feasibility study, anal-
yses were primarily descriptive and focused on baseline 
participant characteristics and the estimation of key feasi-
bility parameters.69 Estimates of recruitment, retention 
and questionnaire completion rates are presented with 
95% CIs. Intervention attendance rates are described.
Preliminary estimates of effect size with 95% CIs are 
presented for the three candidate primary outcomes to 
inform the plausibility of the effect sizes used in future 
sample size calculations. Participants were analysed in 
the group they were randomised to, and we attempted to 
collect outcome measure data from everyone randomised. 
Missing data were assumed to be missing completely at 
random and no imputation methods were used. Analysis 
of covariance was used to estimate the effect size for each 
outcome variable at follow-up, adjusting for centre and 
the respective baseline values. Although stroke severity 
was a stratification variable in the randomisation, we 
have not adjusted for it in the analysis because of the very 
small number with severe stroke. In the future trial we 
would also take into account clustering effects resulting 
from the group-based nature of the HoS intervention.70 
We have not taken into account clustering in the anal-
ysis presented here because (1) this is a feasibility study 
where the aim is not to obtain precise estimates of effect 
size, and (2) there were just 56 participants (29 receiving 
the HoS intervention) and only a small number of clus-
ters (n=4), making it difficult to adjust for clustering. A 
consequence is that widths of the 95% CIs are likely to 
be underestimated. Standardised effect sizes (Cohen’s d) 
were obtained by dividing effect sizes by pooled baseline 
SD.
Economic analysis
We report completion rates for the resource use catego-
ries. A preliminary estimate of the cost of delivering the 
HoS intervention was derived using macro-level costings. 
We also report artist facilitator time to deliver the inter-
vention at the micro-level and participant travel expenses 
incurred attending the HoS sessions.
We further report resource use units and costs per cate-
gory per trial arm, for an indication of cost drivers for the 
intervention from the health and social care perspective. 
We derived capability index scores for the ICECAP-A71 
and applied UK preference-based tariffs to the Short 
Form-6 Dimensions (SF6-D) to derive quality adjusted life 
years (QALYs).72
Qualitative analysis
The qualitative analysis consisted of two aspects: (1) a 
content analysis73 of participants’ views of the research 
processes, which is presented in this paper; and (2) a 
thematic analysis74 of participants’ expectations and 
experiences of the HoS group, which will be reported 
separately.
The interviews were transcribed verbatim. For the 
content analysis CE-H read each transcript and for each 
one noted responses to the specific questions relating to 
the research processes; such as recruitment, screening 
and the administration of outcome measures, as well 
as the acceptability of the venue, the intervention and 
potential willingness to pay for the intervention (latter 
three, intervention group only). These specific responses 
were then collated across participants by CE-H. 
study procedures, recruitment and retention rates
Fifty-six people were randomised (88% of our original 
target of 64) (see figure 3). Nearly two-thirds of the 
sample were male, the mean age of the sample was 70 
(SD 12.1) years, and the mean time since stroke was 9 
(SD 6.1) months. Approximately 80% of participants had 
had an ischaemic stroke. Seventy per cent of the sample 
was retired (see table 1). One participant who had had 
their stroke outside the 2-year poststroke inclusion time 
window (32 months poststroke) was erroneously recruited 
into the study. We included this participant’s data in the 
analysis.
Participants were enrolled into the study between 
August 2014 and April 2015 and the final follow-up 
occurred in December 2015. The recruitment rate across 
both centres was 14% (95% CI 11% to 17%). In Bour-
nemouth, an acute hospital setting, the recruitment rate 
was 11% (95% CI 8% to 14%), and in Cambridgeshire, 
a community setting, it was 28% (95% CI 19% to 38%).
In total, information about the study was given or 
sent to 396 people (313 in Bournemouth and 83 in 
Cambridgeshire). Of these, 198 people declined partic-
ipation, 112 did not return the reply slip, 4 did not meet 
the inclusion criteria, and 26 were excluded for ‘other 
reasons’ (see figure 3).
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Six participants (11%) withdrew from both the study 
and follow-up data collection and three participants (5%) 
did not return the main outcome measures at follow-up. 
For two of the three proposed potential primary outcomes 
(HADS and ICECAP-A), 47 of 56 (84% (95% CI 73% to 
92%)) of the randomised participants had complete base-
line and follow-up data, and 46 of 56 (82% (95% CI 70% 
to 91%)) had complete baseline and follow-up data for 
the WEMWBS.
reasons for non-participation
Of 198 people declining participation, 89 gave reasons, 
the most common ones related to not being interested/
feeling the intervention “wasn’t for them” (n=27) and 
health reasons (n=14).
Delivery, attendance rates and group size
Five participants allocated to the HoS arm declined the 
intervention postrandomisation (see CONSORT diagram 
for reasons). Of the 29 participants randomised to the 
HoS intervention, 20 (69% (95% CI 51% to 84%)) 
attended 6 or more of the 10 sessions.
Two HoS groups were delivered in Bournemouth (iter-
ations 1 and 2) and two in Cambridgeshire (iterations 3 
and 4). The timing of the HoS sessions deviated slightly 
from that specified in the original protocol in three of the 
four iterations due to venue availability and the timing of 
public holidays. The planned group size was six to eight 
participants, and this target was mostly met in iterations 1–3 
with 73% (22/30) of the delivered sessions including six 
or more people. In iteration 4, due to time pressures (the 
grant coming to an end), only 11 people were randomised, 
with 6 allocated to the intervention. There were two drop-
outs before the group commenced and one person with-
drew after the first session, meaning that 90% of sessions 
included three people or fewer. A summary of attendance 
at the HoS groups broken down by centre and session is 
presented in online supplementary table S1. Seventy-two 
per cent of the participants randomised to the HoS arm 
attended the final session (session 10) of the HoS group 
intervention.
Self-reported ratings on the domains of Doosje et al’s 
Social Identification self-report scale (measuring ‘sense of 
Figure 3 Consolidated Standards of Reporting Trials diagram. HoS, HeART of Stroke.
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Table 1 Baseline clinical and demographic descriptives for the sample
Descriptors
Usual care
(n=27)
HeART of Stroke
(n=29)
Entire cohort
(n=56)
Sex, n (%)
  female; male 7 (26); 20 (74) 17 (59); 12 (41) 24 (43); 32 (57)
Age (years), mean (SD) range 67.4 (12.83) 39–88 72.0 (11.22) 27–87 69.8 (12.13) 27–88
Ethnicity, n (%)
  White English 25 (93) 23 (79) 48 (86)
  White other British 1 (4) 5 (17) 6 (11)
  Mixed-white and Asian 1 (4) – 1 (2)
  Black or black British-African – 1 (3) 1 (2)
Time since stroke (months), median (IQR) range* 7 (5) 2–19 7 (7) 1–32 7 (5) 1–32
Stroke type, n (%)
  Ischaemic/thrombotic 6 (22) 5 (17) 11 (20)
  Ischaemic/embolic 1 (4) 1 (3) 2 (4)
  Haemorrhagic/intracerebral 2 (7) 2 (7) 4 (7)
  Haemorrhagic/subarachnoid – 1 (3) 1 (2)
  Ischaemic/type unknown 13 (48) 16 (55) 29 (52)
  Haemorrhagic/type unknown 4 (15) 3 (10) 7 (13)
  Type unknown 1 (4) 1 (3) 2 (4)
Stroke severity (Rivermead Motor Assessment - gross function subscale), n (%)
  Total score ≤6 1 (4) 2 (7) 3 (5)
  Total score ≥7 26 (96) 27 (93) 53 (95)
Stroke side, n (%)
  Left 11 (42) 15 (52) 26 (47)
  Right 13 (50) 11 (38) 24 (44)
  Both sides 1 (4) 3 (10) 4 (7)
  Not applicable 1 (4) – 1 (2)
  Missing 1 – 1
Centre, n (%)
  Bournemouth 16 (59) 17 (59) 33 (59)
  Cambridgeshire 11 (41) 12 (41) 23 (41)
Level of education (highest qualification), n (%)
  No qualifications 3 (12) 8 (30) 11 (21)
  One or more General Certificate of Secondary 
Education (GCSE) or equivalent
4 (16) 4 (15) 8 (15)
  One or more General Certificate of Education (GCE) 
A- (Advanced) level or equivalent
5 (20) 1 (4) 6 (12)
  First degree or higher 1 (4) 5 (19) 6 (12)
  Other 12 (48) 9 (33) 21 (40)
  Missing 2 2 4 
Prestroke employment status, n (%)
  Retired 14 (52) 25 (86) 39 (70)
  Full-time employment 3 (11) 1 (3) 4 (7)
  Part-time employment 3 (11) 1 (3) 4 (7)
  Self-employed 2 (7) 1 (3) 3 (5)
  Other (unemployed;  
home maker)
5 (19) 1 (3) 6 (11)
Continued
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belonging’)55 increased across sessions and remained high 
in the final session (see online supplementary table S2).
support requirements for hos group members
At the Cambridgeshire centre, one of the artist facilitators 
discussed a HoS group member’s cognitive needs with FG 
(clinical psychology). Subsequently, several adaptations 
were identified and implemented, such as providing a 
small sketchpad when needing to wait for additional 
support and providing instructions one step at a time.
suitability of the outcome measures and feasibility of the 
assessment strategy
The ACE-R was originally designed as a screening tool for 
dementia and provides a single overall total score, with 
higher scores indicating better cognitive functioning. It 
relies heavily on language abilities, meaning that people 
with aphasia can perform poorly on domains such as 
memory because of language impairments.75 It did not 
prove suitable for our sample, of whom nearly half (46%) 
had some degree of language difficulty. For this reason we 
have not presented the baseline descriptive data for the 
ACE-R as we do not feel they provide an accurate summary 
of the sample’s cognitive abilities given that some of the 
domains rely on verbal fluency and expression.
Overall, participants found the self-reported outcome 
measures acceptable and were able to complete 
them, sometimes requiring support. However, several 
participants noted to the blinded assessors that they had 
found the HISDS-III difficult to complete (in terms of 
understanding the meaning of some of the bipolar adjec-
tive pairs and also in understanding the response format 
of the scale). These difficulties were reflected in some 
of the polarised response patterns obtained and corrob-
orated by the blinded assessors’ experiences. For these 
reasons we have not presented these data.
Missing questionnaire data were followed up via tele-
phone by a research assistant (baseline) or blinded 
assessor (follow-up) at each centre. Levels of missing 
data were very low—overall, 99.8% of the questionnaire 
items comprising the candidate primary outcomes were 
completed (1809/1815 items at baseline and 1550/1551 
items at follow-up) by those who provided outcomes (at 
baseline n=55 and follow-up n=47).
support requirements to complete outcomes
At follow-up, the self-report questionnaire booklets were 
administered via post by default, but face-to-face support 
was provided if required/requested. Fifty-eight per cent 
of those with follow-up data (26/45, data for 2 cases 
missing) reported that they completed the questionnaire 
booklet with no support, 8 (18%) received support from 
the blinded assessor in the home, 10 (22%) received 
support from family and friends, and 1 (2%) received 
telephone support from the blinded assessor.
Descriptors
Usual care
(n=27)
HeART of Stroke
(n=29)
Entire cohort
(n=56)
Marital status, n (%)
  Single 4 (15) 3 (10) 7 (13)
  Married/cohabiting 17 (63) 13 (45) 30 (54)
  Separated/divorced 3 (11) 3 (10) 6 (11)
  Widowed 3 (11) 10 (34) 13 (23)
Household composition, n (%)
  Living alone 9 (33) 13 (45) 22 (39)
  Living with others 18 (67) 15 (52) 33 (59)
  Sheltered housing – 1 (3) 1 (2)
Taking medication for mood, n (%)
  No 21 (78) 24 (86) 45 (82)
  Yes 6 (22) 4 (14) 10 (18)
  Missing – 1 1
Communication difficulties†, n (%)
  No 18 (67) 12 (41) 30 (54)
  Yes 9 (33) 17 (59) 26 (46)
Motricity Index total score‡, median (IQR), n 100 (27) 12–100, 27 84 (29) 1–100, 29 84.5 (27) 1-100, 56
*Although the inclusion criterion for the study was ≤24 months poststroke, we erroneously recruited one participant at 32 months poststroke 
and this participant’s data are included in the analysis.
†Boston Severity Rating Scale.
‡For one case there was a missing value for one item and this was replaced by the mean. 
Table 1 Continued 
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Possible primary outcomes
In table 2 we present descriptives for the possible primary 
outcomes (WEMWBS, HADS-anxiety subscale (HADS-
A), HADS-depression subscale (HADS-D), ICECAP-A), 
and descriptives for all other outcomes gathered are 
presented in online supplementary table S3.
Completion of resource use questionnaire
The resource use questionnaire was completed by 50 of 
56 participants (89%): 25 of 29 patients in the HoS arm 
and 25 of 27 patients in the usual care arm. Of these, 33 
(66%) were administered over the telephone, 16 (32%) 
face-to-face at home and 1 (2%) via the post. Although 
not included in the original study protocol, duration data 
were logged in the Bournemouth centre, with the 19 
telephone interviews lasting 23 min (SD=10) on average 
and the 8 face-to-face administrations in the home lasting 
38 min (SD=13) on average.
Completion rates of resource use categories were high 
and similar between the two study arms (table 3). The least 
completed category was community-based services, such 
as primary care visits (see table 3), with 90% complete 
data for this category (both trial arms combined). Seven-
ty-nine per cent complete data (out of the full sample) 
are available for an economic analysis from the health 
and social care perspective.
Assessor allocation guesses
At the Cambridgeshire centre, due to a delay in receiving 
approval for patient access for the blinded assessor, the 
unblinded research assistant administered follow-up 
outcomes to six participants. Overall 50 of 56 participants 
(Cambridgeshire=23; Bournemouth=27) completed ques-
tionnaire outcome measures and/or telephone resource 
use questionnaires at follow-up. In Cambridgeshire, the 
blinded assessor correctly guessed allocation on 9 of 17 
(53%) occasions (p=1.00 using the exact binomial test to 
compare with expected percentage of 50%). (NB: The 
six outcome assessment occasions in Cambridgeshire that 
were not undertaken by a blinded assessor are excluded.) 
In Bournemouth, the blinded assessor correctly guessed 
allocation on 24 of 27 (89%) occasions (p<0.001). Thus 
overall the blinded assessors correctly guessed alloca-
tion on 33 of 44 (75% (95% CI 61% to 85%)) occasions 
(p=0.001).
sAes and Aes
Five SAEs were reported during the study period. None 
was deemed related to the intervention. These included 
admissions to hospital for bunion removal, facial weak-
ness and vomiting, atrial fibrillation, pneumonia, and a 
transient ischaemic attack.
Five AEs were noted. None was deemed related to 
the intervention. Four people attended the emergency 
department but were not admitted (water retention, fall 
at home, fall in the road, anxiety). One person sustained 
a minor injury to their arm at home.
Cost of delivering the hos intervention
The cost of delivering the HoS intervention was £1960 in 
Bournemouth and £2530 in Cambridgeshire, reflecting 
higher venue hire costs in Cambridgeshire (see table 4). 
On average, six participants attended the two HoS iter-
ations held in Bournemouth and four attended the two 
HoS iterations held in Cambridgeshire. The HoS inter-
vention would cost the healthcare payer, on average, 
£327 per participant in Bournemouth and £657 in 
Cambridgeshire. The cost could be as low as £245 per 
participant at a full capacity of 8 people.
health-related quality of life gain, resource use and costs
Table 5 reports the QALY gains from baseline and 
resource use and costs for the HoS and usual care arms. 
Potential cost drivers for the intervention are inpatient 
and outpatient appointments and contacts with a social 
worker.
Acceptability of study processes and intervention logistics
All 12 people who were purposively sampled for inter-
view (8 intervention, 4 usual care) were interviewed on 
two occasions (male=7, female=5; mean age=70 years 
(range 51–83 years); mean time since stroke=7 months 
(range 4–12 months); mean interview duration 40 min 
(range 10–65 min)). Most had had a mild and one a 
moderately disabling stroke. Nine had an affected arm 
and five had speech difficulties. Participants were posi-
tive about the study processes and reported finding the 
screening and baseline measures easy to complete with 
the support provided (“not too bad”, or “no trouble, it 
was quite straightforward”). One person commented 
negatively on the cognitive assessment as her husband 
who lived with dementia had had to complete it in the 
past. Participants found the outcome measures and 
resource use questionnaire acceptable (“it was all right, 
yeah”; “no problems, no problems at all”). Some people 
valued receiving the resource use log to complete as they 
went along saying “it was helpful to do it beforehand”, 
or using the paper versions of questionnaires that were 
sent in advance to supplement telephone interviews 
saying it was not a problem due to “the fact that I had 
it in front of me as well”. One person noted they would 
have liked more opportunities for open answers on the 
questionnaires so they could provide some explanations 
about their responses. All interviewees would have been 
happy to complete outcome measures at 4 and 12 months 
follow-up, if asked.
Timing of sessions (held in the morning) and session 
duration (2 hours) were acceptable. While the venues 
were found to be satisfactory, a few people mentioned 
that they would have liked access to a café where they 
could meet following the HoS sessions. Participants in 
Bournemouth were willing to pay up to £10 per session 
for transport if required. As all but one interviewee in 
Cambridgeshire drove to sessions (it was a much more 
rural setting than Bournemouth) and were happy to 
do so, transport costs were not discussed during the 
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interviews. The one interviewee who used transport in 
Cambridgeshire only attended one session due to health 
issues (unrelated to stroke). Findings related to expecta-
tions and experiences of taking part in the groups will be 
reported elsewhere.
DIsCussIOn
Main findings
This is the first study to formally test the feasibility of an 
arts and health intervention for people poststroke in 
the community. While there are two other RCTs of arts 
and health interventions in stroke,46–48 both of these 
involved inpatients in a rehabilitation setting rather than 
people living in the community. One involved a creative 
art intervention that, unlike HoS, was highly prescribed, 
making direct comparisons difficult.
Attendance at the HoS intervention groups was high. 
The majority of people who took part in the HoS groups 
highly valued them, with many reporting increased confi-
dence both within and outside the groups. The numbers 
who declined the intervention were similar to those 
reported in the Morris et al study.47 48 Study retention was 
good (with follow-up data available for 84% of partic-
ipants) and high data completion rates (>80% for the 
candidate primary outcome measures).
The structured breaks between the HoS sessions were 
potentially instrumental in encouraging participants to 
continue artwork outside the group. The links created 
Table 3 Completeness of resource use data
Complete 
data (n)
% of 
questionnaires 
filled in (n=25)
% of sample
(n=29)
Complete 
data (n)
% of 
questionnaires 
filled in (n=25)
% of sample
(n=27)
Intervention Usual care
Health and social care
  Outpatient visits 25 100 86 25 100 93
  Inpatient visits 25 100 86 25 100 93
  Community-based services 21 84 72 24 96 89
  Personal social services 25 100 86 24 96 89
  Total health and social care 21 84 72 23 92 85
Further resource use collected
  Time off work 25 100 86 23 92 85
  Time off normal activities 25 100 86 25 100 93
  Hours of help per week 21 84 72 24 96 89
  Private therapies used 25 100 86 25 100 93
  Charity/support group contacts 25 100 86 25 100 93
Table 4 HeART of Stroke (HoS) delivery costs
Cost of delivering HoS Bournemouth Cambridgeshire
Costs for 10 sessions
  Artist fee £1200 £1200
  Venue cost £430 £1000
  Materials cost £330 £330
  Total £1960 £2530
  Mean number of participants per session 6.0 3.9
  Cost of HoS per participant (based on mean attendance) £327 £657
  Cost of HoS per participant at capacity (eight attendees) £245 £316
Reporting micro-level resource use to deliver HoS
  Artist time (in mean hours)
  Session duration 20.0 20.5
  Preparation time 20.0 10.6
  Travel time 15.0 15.6
  Total intervention time 55.0 46.7
  Participant travel costs £1021 £658
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with local arts and health practitioners led to some partic-
ipants continuing more independent creative practice 
after the research ended. Important practical consid-
erations include ensuring that venues are on public or 
community transport routes, have free and disabled car 
parking facilities, heating/air conditioning and drink-
making facilities. In the full multicentre trial, to maximise 
recruitment and be as inclusive as possible, transport will 
be provided, if required.
The included outcome measures were mostly accept-
able (but see the Limitations: implications for a future 
trial section), with some participants requiring support to 
complete them. The possible primary outcome measures 
for the future trial (WEMWBS, HADS-D, HADS-A, 
ICECAP-A) all demonstrated change in the direction of 
benefit for the HoS arm. In Morris et al’s randomised 
controlled feasibility study of a visual arts participation 
intervention for inpatients with stroke, a quality of life 
scale was initially suggested as the likely primary outcome 
for a future trial. However, their findings suggested 
that a measure of emotional well-being (the Positive 
and Negative Affect Scale) would be a more relevant 
primary outcome measure. Similarly, in the current study 
a measure of emotional well-being (HADS-D) is being 
considered as the primary outcome for a subsequent 
definitive trial and, with medium standardised effect 
sizes, it is likely that such a trial would be feasibly sized.
We have used novel dissemination methods such as 
making a short film involving people who attended the 
HoS groups in Bournemouth, and holding an art exhibi-
tion in both Bournemouth and Cambridgeshire to show-
case the creations of the HoS group members.
Limitations: implications for a future trial
We did not quite reach our original recruitment target 
and the overall recruitment rate was low (although 
not unlike that reported in another community-based 
study76). In the current study, the recruitment rate in the 
community setting (28%) was higher than that via hospi-
tals (11%). This might be because in Cambridgeshire 
recruitment was undertaken by clinicians working in 
the community who often had a long-standing relation-
ship with their clients. In contrast, at Bournemouth and 
Christchurch hospitals, while some potential participants 
were known to and approached directly by the research 
nurses, others were identified from clinical databases and 
sent study information in the post.
The most common reason for people declining partic-
ipation in the current study was because they felt the 
intervention “wasn’t for them”. Similarly Morris et al48 
reported that the majority of people who declined partic-
ipation in their feasibility study of a visual arts participa-
tion programme did so because they were ambivalent 
about art participation. Modifying the description of the 
HoS intervention, such as referring to it as ‘an opportu-
nity to reconnect with and gain confidence in everyday 
life’, rather than calling it an arts intervention could be 
one way to enhance recruitment. Morris et al suggested 
that provision of taster sessions may be another means 
of improving study enrolment,48 although we note a risk 
of jeopardising equipoise or increasing the likelihood of 
resentful demoralisation. Additionally, we could extend 
the eligibility criteria by providing additional support 
so that those who require support with toileting needs 
could attend, although this would have cost implications. 
Finally, we could also expand the recruitment strategy to 
include primary care. We will continue to consult with 
service users and stakeholders to seek their advice on ways 
of increasing recruitment rates and how best to convey 
the essence of the intervention to people.
The resource use data obtained in this feasibility study 
provide insights into the main potential cost drivers for 
the intervention, meaning that we can refine and shorten 
the resource use questionnaire for the definitive trial. 
While administering the resource use questionnaire 
by telephone resulted in high levels of data complete-
ness, maintaining assessor blinding at follow-up proved 
challenging, particularly in the Bournemouth centre. 
To try to increase the success of assessor blinding, we 
will add instructions on the printed versions of the 
outcome measures that emphasise the importance of not 
disclosing allocation group and will reword the question 
in the resource use questionnaire that asks about contacts 
with charities, social or activity groups. We will also seek 
patient and public involvement advice about how we 
can best convey the message not to disclose allocation 
at the start of the telephone resource use interview, and 
based on this will create a standard script. We will provide 
training for the blinded assessors.
Some participants reported finding the HISDS-III diffi-
cult to complete. For these reasons we would not include 
this outcome in a future trial. The ACE-R also proved 
problematic due to its reliance on language abilities. It 
will be important to identify a more appropriate way to 
evaluate specific domains of cognitive functioning for 
the future trial. One possibility is the Oxford Cognitive 
Screen,75 which has been designed specifically with a 
stroke population in mind and is purportedly inclusive 
for individuals with aphasia and neglect.
Only short-term follow-up was included in this feasibility 
study. However, a future definitive study would include a 
longer term 12-month follow-up.
The idea for the HoS intervention originated from a 
stroke survivor (and coauthor) (RC) who had identified 
a gap in service provision. Since then, arts and health 
approaches are beginning to be recognised by policy 
makers as a useful way to support the health and well-
being of communities.39 With NHS pressures and difficul-
ties of accessing formal services,77 our relatively low-cost 
intervention (which could be as low as £245 per person if 
delivered at full capacity) offers potential to form part of a 
comprehensive long-term support pathway to reduce the 
likelihood of depression following a stroke and increase 
community access and participation. As we look ahead 
to a future definitive trial, it will be important to draw 
on implementation science expertise and to consult with 
 o
n
 11 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-021098 on 8 March 2019. Downloaded from 
16 Ellis-Hill C, et al. BMJ Open 2019;9:e021098. doi:10.1136/bmjopen-2017-021098
Open access 
key stakeholders. This will help us to ensure that the HoS 
intervention, if found to be effective and cost-effective, 
can be rolled out within existing health service and social 
care structures and is designed in such a way so as to facil-
itate its rapid adoption and implementation into practice.
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